Filing Details

Accession Number:
0001140361-12-033090
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-13 14:32:59
Reporting Period:
2012-07-12
Filing Date:
2012-07-13
Accepted Time:
2012-07-13 14:32:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911326 Synageva Biopharma Corp GEVA Biological Products, (No Disgnostic Substances) (2836) 561808663
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1111794 R Daniel Tisch 500 Park Avenue
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-12 29,200 $46.75 186,357 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 167,912 Indirect Through trusts
Common Stock 44,750 Indirect Through family partnership
Footnotes
  1. This statement is being filed solely for informational purposes because of family relationships. The filing of this statement is not an admission that the reporting person and any other person or persons constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934 or Rule 13d-5 thereunder or for any other purpose, and the reporting person disclaims beneficial ownership of any shares of the Issuer other than those reported herein.